Where does Leiden University Medical Center rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Leiden University Medical Center ranks #26,734 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Leiden University Medical Center hold?

Leiden University Medical Center holds 10 US utility patents granted between 2015 and 2020, spanning 11 technology areas.

What is Leiden University Medical Center's Innovation Score?

Leiden University Medical Center has an Innovation Score of 26.4 out of 100 (20th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Leiden University Medical Center's patent grant rate increasing or decreasing?

Leiden University Medical Center's recent grant velocity is -57% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Leiden University Medical Center's patents?

Leiden University Medical Center's patents average 10.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Leiden University Medical Center patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Leiden University Medical Center

Q: What technology areas does Leiden University Medical Center focus on?

Leiden University Medical Center's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 6 patents. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 11 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Leiden ranks #26,734 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 11 technology areas.

#26,734
of 49,997 US assignees by volume: 20th percentile
by Innovation Score (26.4/100): 10.7
avg claims per patent: -57%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26734 · Foreign Corporation #26,734 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,734/49,997
PHOTO-FINISH Larose Industries
CPC-FOCUS A61P · 11 areas
INNOV-THIN 26.4/100
CLAIMS-PAR 10.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -57% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Larose Industries, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Leiden University… · this assignee

26
3D Lighting… · lowest

7

What this shows Leiden's Innovation Score is 26.4/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Leiden's grants concentrate

Leiden University Medical Center is a focused PatentsView assignee: 11 CPC subclasses with 60% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2015. By volume, Leiden sits between Larose Industries, LLC and Leverton Holding LLC.

Larose Industries

10
Lcdrives

10
Leap Semiconductor

10
Learningmate Solu…

10
Lenovo (Singapore…

10
Leone S P A

10
LES Solutions MÉD…

10
Leverton Holding

10
Leiden University… ◀

10

What this shows Leiden holds 10 patents at rank #26,717, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Leiden

By rank, the assignees closest to #26,717 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Leiden's primary technology class.

Leiden's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 20th percentile higher than 20% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Leiden University Medical Center patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	10.0%
2017	2	20.0%
2018	3	30.0%
2019	1	10.0%
2020	3	30.0%

Which technologies does Leiden University Medical Center patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C07K - Peptides 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

C07D - Heterocyclic Compounds 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

C12Y - Enzymes 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 11 of 11 technology areas

Where it ranks

Overall rank by patents

#26,734

of 49,997 tracked assignees

Innovation Score

26.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Leiden University Medical Center's patent record in context - here's where to go next.

Leiden University Medical Center's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 60% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #26,734 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Leiden University Medical Center against Larose Industries, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.